Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	2.60e-07	18	162	5	GO:0008569
GeneOntologyMolecularFunction	ATP-dependent activity	DNAH3 ERCC2 ATRX MYO9A WRNIP1 SRP54 DNAH1 HSPA13 TRAP1 MDN1 SMC3 DNAH17 ABCD4 KIF28P MACF1 SLFN11 DNAH6 TOP2A DNAH11	6.15e-07	614	162	19	GO:0140657
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DNAH1 SMC3 DNAH17 KIF28P DNAH6 DNAH11	1.59e-06	70	162	7	GO:0003777
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	2.79e-06	28	162	5	GO:0051959
GeneOntologyMolecularFunction	ATP hydrolysis activity	DNAH3 ERCC2 ATRX WRNIP1 SRP54 HSPA13 TRAP1 MDN1 SMC3 ABCD4 KIF28P MACF1 SLFN11 DNAH6 DNAH11	3.23e-06	441	162	15	GO:0016887
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 MYO9A DNAH1 SMC3 DNAH17 KIF28P DNAH6 DNAH11	5.42e-06	118	162	8	GO:0003774
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	1.17e-05	37	162	5	GO:0045505
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	DNAH3 ERCC2 ATRX WRNIP1 SRP54 HSPA13 TRAP1 MDN1 SMC3 RASL11A HRAS ABCD4 KIF28P MACF1 SLFN11 DNAH6 DNAH11	1.93e-04	775	162	17	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	DNAH3 ERCC2 ATRX WRNIP1 SRP54 HSPA13 TRAP1 MDN1 SMC3 RASL11A HRAS ABCD4 KIF28P MACF1 SLFN11 DNAH6 DNAH11	4.83e-04	839	162	17	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	DNAH3 ERCC2 ATRX WRNIP1 SRP54 HSPA13 TRAP1 MDN1 SMC3 RASL11A HRAS ABCD4 KIF28P MACF1 SLFN11 DNAH6 DNAH11	4.89e-04	840	162	17	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	DNAH3 ERCC2 ATRX WRNIP1 SRP54 HSPA13 TRAP1 MDN1 SMC3 RASL11A HRAS ABCD4 KIF28P MACF1 SLFN11 DNAH6 DNAH11	4.89e-04	840	162	17	GO:0016818
GeneOntologyMolecularFunction	integrin binding	LAMA5 ITGA6 ITGA1 ITGAL SVEP1 SLC6A4 CD226	5.75e-04	175	162	7	GO:0005178
GeneOntologyCellularComponent	postsynaptic membrane	GABRG2 CACNA1C PCDHB13 PCDHB8 GRM1 CSMD2 SLC1A6 SLC6A4 SCN8A DLG4 ADGRL2 GABRA3 EPHA7	1.83e-05	405	163	13	GO:0045211
GeneOntologyCellularComponent	cilium	DNAH3 DCDC2 DCDC2C PSEN1 TBC1D30 PCDHB13 PCDHB8 CFAP43 ADGRV1 GARIN2 DNAH1 PIK3R4 TTLL2 DNAH17 PKD1 USH2A DNAH6 CNGA3 HYDIN DNAH11	2.38e-05	898	163	20	GO:0005929
GeneOntologyCellularComponent	axoneme	DNAH3 DCDC2 CFAP43 DNAH1 PIK3R4 DNAH17 DNAH6 HYDIN DNAH11	3.69e-05	207	163	9	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	DNAH3 DCDC2 CFAP43 DNAH1 PIK3R4 DNAH17 DNAH6 HYDIN DNAH11	3.84e-05	208	163	9	GO:0097014
GeneOntologyCellularComponent	axonemal dynein complex	DNAH3 DNAH1 DNAH17 DNAH6	3.97e-05	25	163	4	GO:0005858
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAH3 DCDC2 CFAP43 DNAH1 PIK3R4 DNAH17 AP3B2 DLG4 DNAH6 HYDIN DNAH11	4.07e-05	317	163	11	GO:0032838
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH1 DNAH6	5.37e-05	10	163	3	GO:0036156
GeneOntologyCellularComponent	dynein complex	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	6.30e-05	54	163	5	GO:0030286
GeneOntologyCellularComponent	cytoplasmic region	DNAH3 DCDC2 CFAP43 DNAH1 PIK3R4 DNAH17 AP3B2 DLG4 DNAH6 HYDIN DNAH11	1.26e-04	360	163	11	GO:0099568
GeneOntologyCellularComponent	postsynaptic specialization membrane	GABRG2 CACNA1C GRM1 CSMD2 SCN8A DLG4 GABRA3 EPHA7	1.85e-04	201	163	8	GO:0099634
GeneOntologyCellularComponent	synaptic membrane	GABRG2 CACNA1C PSEN1 PCDHB13 PCDHB8 GRM1 CSMD2 SLC1A6 SLC6A4 SCN8A DLG4 ADGRL2 GABRA3 EPHA7	1.98e-04	583	163	14	GO:0097060
GeneOntologyCellularComponent	USH2 complex	ADGRV1 USH2A	3.59e-04	4	163	2	GO:1990696
GeneOntologyCellularComponent	photoreceptor connecting cilium	PCDHB13 PCDHB8 ADGRV1 USH2A	5.31e-04	48	163	4	GO:0032391
GeneOntologyCellularComponent	9+2 motile cilium	DNAH3 DCDC2C CFAP43 GARIN2 DNAH1 DNAH17 DNAH6 DNAH11	5.74e-04	238	163	8	GO:0097729
GeneOntologyCellularComponent	receptor complex	GABRG2 FLT4 ITGA6 ITGA1 ADGRV1 GRM1 ITGAL PLXNB2 PTPRB PTPRQ DLG4 ALCAM GABRA3	6.51e-04	581	163	13	GO:0043235
GeneOntologyCellularComponent	stereocilia ankle link	ADGRV1 USH2A	8.88e-04	6	163	2	GO:0002141
GeneOntologyCellularComponent	stereocilia ankle link complex	ADGRV1 USH2A	8.88e-04	6	163	2	GO:0002142
GeneOntologyCellularComponent	stereocilium membrane	ADGRV1 USH2A	8.88e-04	6	163	2	GO:0060171
GeneOntologyCellularComponent	periciliary membrane compartment	ADGRV1 USH2A	8.88e-04	6	163	2	GO:1990075
GeneOntologyCellularComponent	postsynaptic density membrane	CACNA1C GRM1 CSMD2 SCN8A DLG4 EPHA7	1.47e-03	157	163	6	GO:0098839
GeneOntologyCellularComponent	stereocilia coupling link	ADGRV1 USH2A	1.64e-03	8	163	2	GO:0002139
GeneOntologyCellularComponent	microtubule associated complex	DNAH3 DNAH1 DNAH17 KIF28P DNAH6 DNAH11	1.67e-03	161	163	6	GO:0005875
GeneOntologyCellularComponent	motile cilium	DNAH3 DCDC2C CFAP43 GARIN2 DNAH1 DNAH17 PKD1 DNAH6 DNAH11	1.93e-03	355	163	9	GO:0031514
GeneOntologyCellularComponent	integrin complex	ITGA6 ITGA1 ITGAL	1.96e-03	32	163	3	GO:0008305
GeneOntologyCellularComponent	postsynapse	GABRG2 CACNA1C PSEN1 MYO9A PCDHB13 PCDHB8 GRM1 CSMD2 SLC1A6 SLC6A4 MTOR SCN8A MACF1 DLG4 ADGRL2 GABRA3 EPHA7	2.56e-03	1018	163	17	GO:0098794
GeneOntologyCellularComponent	cell surface	CACNA1C PSEN1 NRDC ITGA6 CP ITGA1 ADGRV1 DCSTAMP ITGAL PLXNB2 NFAM1 CFHR4 CD226 PKD1 C3 CAPN5 ALCAM IL1R1	2.65e-03	1111	163	18	GO:0009986
GeneOntologyCellularComponent	monoatomic ion channel complex	GABRG2 CACNA1C KCNB2 KCNH6 PKD1 SCN8A DLG4 CNGA3 GABRA3	2.93e-03	378	163	9	GO:0034702
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH1 MDN1 DNAH6 DNAH11	7.42e-08	14	157	5	IPR011704
Domain	AAA_5	DNAH3 DNAH1 MDN1 DNAH6 DNAH11	7.42e-08	14	157	5	PF07728
Domain	VWFA	COL6A3 CPNE8 COL12A1 ITGA1 ITGAL SVEP1 MDN1 ITIH6	4.39e-07	82	157	8	PS50234
Domain	VWA	COL6A3 CPNE8 COL12A1 ITGA1 ITGAL SVEP1 MDN1 ITIH6	5.29e-07	84	157	8	SM00327
Domain	VWF_A	COL6A3 CPNE8 COL12A1 ITGA1 ITGAL SVEP1 MDN1 ITIH6	1.87e-06	99	157	8	IPR002035
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH1 DNAH6 DNAH11	4.50e-06	14	157	4	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH1 DNAH6 DNAH11	4.50e-06	14	157	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH1 DNAH6 DNAH11	4.50e-06	14	157	4	IPR013602
Domain	DHC_N2	DNAH3 DNAH1 DNAH6 DNAH11	4.50e-06	14	157	4	PF08393
Domain	MT	DNAH3 DNAH1 DNAH6 DNAH11	4.50e-06	14	157	4	PF12777
Domain	AAA_8	DNAH3 DNAH1 DNAH6 DNAH11	4.50e-06	14	157	4	PF12780
Domain	DHC_fam	DNAH3 DNAH1 DNAH6 DNAH11	6.10e-06	15	157	4	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH1 DNAH6 DNAH11	6.10e-06	15	157	4	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH1 DNAH6 DNAH11	6.10e-06	15	157	4	IPR004273
Domain	VWA	COL6A3 COL12A1 ITGA1 ITGAL SVEP1 ITIH6	7.36e-06	56	157	6	PF00092
Domain	Sushi	CSMD2 SVEP1 CFHR4 CSMD1 MASP2	7.44e-05	52	157	5	PF00084
Domain	CCP	CSMD2 SVEP1 CFHR4 CSMD1 MASP2	8.93e-05	54	157	5	SM00032
Domain	SUSHI	CSMD2 SVEP1 CFHR4 CSMD1 MASP2	1.06e-04	56	157	5	PS50923
Domain	Sushi_SCR_CCP_dom	CSMD2 SVEP1 CFHR4 CSMD1 MASP2	1.16e-04	57	157	5	IPR000436
Domain	-	COL12A1 LAMA5 ADGRV1 SVEP1 FAT2 USH2A	1.50e-04	95	157	6	2.60.120.200
Domain	GPS	ADGRV1 ADGRL4 PKD1 ADGRL2	1.83e-04	34	157	4	SM00303
Domain	-	DNAH3 ERCC2 ATRX WRNIP1 NDST4 SRP54 DNAH1 MDN1 SMC3 RASL11A HRAS ABCD4 DLG4 SLFN11 DNAH6 HYDIN DNAH11	1.85e-04	746	157	17	3.40.50.300
Domain	GPS	ADGRV1 ADGRL4 PKD1 ADGRL2	2.05e-04	35	157	4	PF01825
Domain	AAA	DNAH3 WRNIP1 SRP54 MDN1 ABCD4 DNAH6 DNAH11	2.18e-04	144	157	7	SM00382
Domain	AAA+_ATPase	DNAH3 WRNIP1 SRP54 MDN1 ABCD4 DNAH6 DNAH11	2.18e-04	144	157	7	IPR003593
Domain	GPS	ADGRV1 ADGRL4 PKD1 ADGRL2	2.30e-04	36	157	4	PS50221
Domain	GPS	ADGRV1 ADGRL4 PKD1 ADGRL2	2.56e-04	37	157	4	IPR000203
Domain	P-loop_NTPase	DNAH3 ERCC2 ATRX MYO9A WRNIP1 NDST4 SRP54 DNAH1 MDN1 SMC3 RASL11A HRAS ABCD4 DLG4 SLFN11 DNAH6 HYDIN DNAH11	2.83e-04	848	157	18	IPR027417
Domain	Integrin_alpha_C_CS	ITGA6 ITGA1 ITGAL	3.01e-04	16	157	3	IPR018184
Domain	-	COL6A3 COL12A1 SVEP1 MDN1 ITIH6	3.98e-04	74	157	5	3.40.50.410
Domain	Integrin_alpha-2	ITGA6 ITGA1 ITGAL	4.33e-04	18	157	3	IPR013649
Domain	INTEGRIN_ALPHA	ITGA6 ITGA1 ITGAL	4.33e-04	18	157	3	PS00242
Domain	Integrin_alpha2	ITGA6 ITGA1 ITGAL	4.33e-04	18	157	3	PF08441
Domain	Integrin_alpha	ITGA6 ITGA1 ITGAL	4.33e-04	18	157	3	IPR000413
Domain	Int_alpha	ITGA6 ITGA1 ITGAL	5.11e-04	19	157	3	SM00191
Domain	Int_alpha_beta-p	ITGA6 ITGA1 ITGAL	5.11e-04	19	157	3	IPR013519
Domain	FG_GAP	ITGA6 ITGA1 ITGAL	7.98e-04	22	157	3	PS51470
Domain	FG-GAP	ITGA6 ITGA1 ITGAL	1.04e-03	24	157	3	PF01839
Domain	FG-GAP	ITGA6 ITGA1 ITGAL	1.04e-03	24	157	3	IPR013517
Domain	Integrin_dom	ITGA6 ITGA1 ITGAL	1.17e-03	25	157	3	IPR032695
Domain	Laminin_G	COL12A1 LAMA5 FAT2 USH2A	1.43e-03	58	157	4	IPR001791
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	3.63e-06	27	126	5	M47755
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	3.86e-05	43	126	5	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	4.83e-05	45	126	5	M47670
Pathway	WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER	CACNA1C GRM1 MTOR HRAS DLG4	8.09e-05	50	126	5	M39822
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	COL6A3 FLT4 CP ITGA1 MINPP1 LCAT LCN2 LGALS3BP ADGRL4 SERPINA4 FAT2 C3 ALCAM C8B	2.95e-11	257	166	14	16335952
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	COL6A3 DNAJC13 MXRA5 CDHR2 LAMA5 CP ITGA1 ADGRV1 LCN2 LGALS3BP BROX FASN SERPINA4 VPS13D SLC44A1 HPD PKD1 AP1M1 UPK2 CAPN5 ALCAM MASP2	3.76e-09	1016	166	22	19056867
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	4.51e-09	14	166	5	9373155
Pubmed	Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.	COL12A1 CP GC LGALS3BP FASN C3	6.56e-08	44	166	6	31273033
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DNAJC13 ZBTB7C ATRX NUDT21 WRNIP1 SRP54 PIK3R4 DOCK5 FASN TRAP1 MDN1 OTULIN SMC3 MACF1 TOP2A	1.48e-07	582	166	15	20467437
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	ATRX NUDT21 POLR2B WRNIP1 ITGA6 PABPC1 SMC3 MTOR MACF1 CDT1 TOP2A EPHA7	1.73e-07	358	166	12	32460013
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	COL6A3 CPNE8 CDHR2 LAMA5 SI CP GC MINPP1 LCAT LCN2 PABPC1 LGALS3BP BROX FASN SERPINA4 C3 UPK2 CAPN5 C8B MASP2	2.19e-07	1070	166	20	23533145
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	COL6A3 COL12A1 LAMA5 CP LGALS3BP SERPINA4 SPON1	5.87e-07	101	166	7	20551380
Pubmed	Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.	FLT4 LAMA5 ITGA6 ITGA1	1.45e-06	18	166	4	19686679
Pubmed	Proteome-wide characterization of N-glycosylation events by diagonal chromatography.	FLT4 CP LCAT CFHR4 C8B MASP2	1.93e-06	77	166	6	16944957
Pubmed	Phenotype and allele frequencies of some serum protein polymorphisms in populations of the Balkans.	CP GC C3	2.11e-06	6	166	3	15648851
Pubmed	Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.	GABRG2 CACNA1C GRM1 SCN8A GABRA3	2.44e-06	45	166	5	25979088
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	MXRA5 SLC2A9 ADGRV1 SGK2 KCNH6 CSMD1	3.23e-06	84	166	6	15203218
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH3 DNAH1 DNAH11	3.69e-06	7	166	3	9256245
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL6A3 COL12A1 LAMA5 ITGA6 ITGA1	4.15e-06	50	166	5	23658023
Pubmed	Remotely Produced and Axon-Derived Netrin-1 Instructs GABAergic Neuron Migration and Dopaminergic Substantia Nigra Development.	UNC5B ITGA6 ITGA1 PLXNB2	1.25e-05	30	166	4	32562661
Pubmed	Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?	MTOR PKD1	2.26e-05	2	166	2	17102641
Pubmed	Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology.	PSEN1 MTOR	2.26e-05	2	166	2	24411482
Pubmed	Gut Barrier Proteins Mediate Liver Regulation by the Effects of Serotonin on the Non-Alcoholic Fatty Liver Disease.	SLC6A4 MTOR	2.26e-05	2	166	2	32538722
Pubmed	Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.	CSMD2 CSMD1	2.26e-05	2	166	2	24408017
Pubmed	Transcriptional regulation of the presenilin-1 gene controls gamma-secretase activity.	PSEN1 ZMYM5	2.26e-05	2	166	2	20036849
Pubmed	Coexistence of autosomal dominant polycystic kidney disease type 1 and hereditary renal hypouricemia type 2: A model of early-onset and fast cyst progression.	SLC2A9 PKD1	2.26e-05	2	166	2	32166738
Pubmed	Characteristics of Retinitis Pigmentosa Associated with ADGRV1 and Comparison with USH2A in Patients from a Multicentric Usher Syndrome Study Treatrush.	ADGRV1 USH2A	2.26e-05	2	166	2	34638692
Pubmed	Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration.	CFHR4 C3	2.26e-05	2	166	2	32034129
Pubmed	Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation.	ADGRV1 USH2A	2.26e-05	2	166	2	28653555
Pubmed	mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines.	MTOR EIF2AK3	2.26e-05	2	166	2	28423496
Pubmed	Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability.	CACNA1C PKD1	2.26e-05	2	166	2	25888683
Pubmed	System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury.	GRM1 IL1R1	2.26e-05	2	166	2	17881516
Pubmed	Association study of FLT4 and HYDIN single nucleotide polymorphisms with atrial septal defect susceptibility in the Han Chinese population of Southwest China.	FLT4 HYDIN	2.26e-05	2	166	2	38581027
Pubmed	The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.	CSMD2 CSMD1	2.26e-05	2	166	2	21439553
Pubmed	Val1483Ile polymorphism in the fatty acid synthase gene was associated with depressive symptoms under the influence of psychological stress.	SLC6A4 FASN	2.26e-05	2	166	2	21641044
Pubmed	PABPC1 promotes cell proliferation and metastasis in pancreatic adenocarcinoma by regulating COL12A1 expression.	COL12A1 PABPC1	2.26e-05	2	166	2	37506150
Pubmed	Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice.	LAMA5 ITGA6	2.26e-05	2	166	2	8673141
Pubmed	Genomic sequences capable of committing mouse and rat fibroblasts to adipogenesis.	GRM1 PLIN2	2.26e-05	2	166	2	8502564
Pubmed	Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1.	PSEN1 MTCH1	2.26e-05	2	166	2	10551805
Pubmed	Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices.	COL12A1 C3	2.26e-05	2	166	2	9344363
Pubmed	The novel presenilin-1-associated protein is a proapoptotic mitochondrial protein.	PSEN1 MTCH1	2.26e-05	2	166	2	12377771
Pubmed	Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK.	MTOR EIF2AK3	2.26e-05	2	166	2	23160380
Pubmed	Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.	PKD1 IL1R1	2.26e-05	2	166	2	31141402
Pubmed	Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.	LCN2 PKD1	2.26e-05	2	166	2	28341240
Pubmed	Impairment of protein degradation and proteasome function in hereditary neuropathies.	MPZ EIF2AK3	2.26e-05	2	166	2	29076578
Pubmed	Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease.	PSEN1 SLC6A4	2.26e-05	2	166	2	20576032
Pubmed	Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo.	LCN2 PKD1	2.26e-05	2	166	2	18974761
Pubmed	Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype.	ADGRV1 USH2A	2.26e-05	2	166	2	15671307
Pubmed	CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.	ITGAL CD226	2.26e-05	2	166	2	15693793
Pubmed	IL-34 exacerbates pathogenic features of Alzheimer's disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice.	IL34 PSEN1	2.26e-05	2	166	2	37666180
Pubmed	Mutations in DNAH1, which encodes an inner arm heavy chain dynein, lead to male infertility from multiple morphological abnormalities of the sperm flagella.	DNAH1 DNAH11	2.26e-05	2	166	2	24360805
Pubmed	Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ.	ADGRV1 PTPRQ	2.26e-05	2	166	2	22357859
Pubmed	A genetic association study of CSMD1 and CSMD2 with cognitive function.	CSMD2 CSMD1	2.26e-05	2	166	2	27890662
Pubmed	Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.	LAMA5 ITGA6	2.26e-05	2	166	2	16940506
Pubmed	LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell.	ITGAL CD226	2.26e-05	2	166	2	16636013
Pubmed	Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility.	C3 CSMD1	2.26e-05	2	166	2	31604923
Pubmed	Functional specialization of beta-arrestin interactions revealed by proteomic analysis.	DNAH3 CPNE8 CPA1 NSUN2 PABPC1 FASN AP3B2 CNGA3 ARHGEF6	2.35e-05	317	166	9	17620599
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CACNA1C AARS1 POLR2B GC PIK3R4 VPS13D PTPRB MDN1 SMC3 HYDIN ZNF292	2.93e-05	497	166	11	36774506
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	AARS1 PARP14 FASN TRAP1 MACF1 UPK2 ADGRL2 TOP2A SLC25A45	3.37e-05	332	166	9	37433992
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	COL6A3 MXRA5 PARP14 PABPC1 TRAP1 PKD1 DNAH6	3.43e-05	187	166	7	26460568
Pubmed	A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy.	FLT4 UNC5B ITGA6	4.66e-05	15	166	3	23299940
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	AARS1 ERCC2 DNAJC13 COL12A1 NRDC NUDT21 POLR2B LAMA5 SRP54 PLXNB2 PABPC1 LGALS3BP HSPA13 FASN SMC3 CHEK2 MACF1 C3	5.19e-05	1297	166	18	33545068
Pubmed	Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.	ADGRV1 PTPRQ USH2A	5.71e-05	16	166	3	17567809
Pubmed	A unique role of cohesin-SA1 in gene regulation and development.	PCDHB13 PCDHB8 SMC3	5.71e-05	16	166	3	22415368
Pubmed	Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.	FLT4 LAMA5 SVEP1	5.71e-05	16	166	3	28179430
Pubmed	Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB.	ITGA6 ITGA1 CAPN5 ALCAM	5.85e-05	44	166	4	30024968
Pubmed	Novel gene function revealed by mouse mutagenesis screens for models of age-related disease.	SLC26A5 LAMA5 ADGRV1 PTPRQ	5.85e-05	44	166	4	27534441
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	DNAJC13 NUDT21 POLR2B WRNIP1 PABPC1 FASN TRAP1 MDN1 SMC3 MTOR AP1M1 RIC8A	6.14e-05	638	166	12	33239621
Pubmed	Aire's partners in the molecular control of immunological tolerance.	POLR2B PABPC1 SMC3 TOP2A	6.40e-05	45	166	4	20085707
Pubmed	Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population.	VPS13D CSMD1	6.77e-05	3	166	2	20610895
Pubmed	Lipid signalling drives proteolytic rewiring of mitochondria by YME1L.	LPIN1 MTOR	6.77e-05	3	166	2	31695197
Pubmed	Experimental validation of 5 in-silico predicted glioma biomarkers.	PLXNB2 SPON1	6.77e-05	3	166	2	24158112
Pubmed	SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor.	HRAS DLG4	6.77e-05	3	166	2	12427827
Pubmed	Organization of the MASP2 locus and its expression profile in mouse and rat.	MTOR MASP2	6.77e-05	3	166	2	15672593
Pubmed	Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.	MTOR CHEK2	6.77e-05	3	166	2	26447757
Pubmed	Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.	CFHR4 C3	6.77e-05	3	166	2	16023208
Pubmed	Timing of gene expression and oolemma localization of mouse alpha6 and beta1 integrin subunits during oogenesis.	ITGA6 ITGA1	6.77e-05	3	166	2	9698453
Pubmed	GABAA receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits.	GABRG2 GABRA3	6.77e-05	3	166	2	29023704
Pubmed	Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.	PSEN1 ITGAL	6.77e-05	3	166	2	26214837
Pubmed	DNAM-1 controls NK cell activation via an ITT-like motif.	ITGAL CD226	6.77e-05	3	166	2	26552706
Pubmed	Localization of Lutheran, a novel laminin receptor, in normal, knockout, and transgenic mice suggests an interaction with laminin alpha5 in vivo.	LAMA5 ITGA6	6.77e-05	3	166	2	11507772
Pubmed	The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1.	ADGRV1 USH2A	6.77e-05	3	166	2	16434480
Pubmed	Phosphorylation of lipin 1 and charge on the phosphatidic acid head group control its phosphatidic acid phosphatase activity and membrane association.	LPIN1 MTOR	6.77e-05	3	166	2	23426360
Pubmed	Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines.	MTOR PKD1	6.77e-05	3	166	2	31251475
Pubmed	Rare Variants in LAMA5 Gene associated with FLT4 and FOXC2 Mutations in Primary Lymphedema May Contribute to Severity.	FLT4 LAMA5	6.77e-05	3	166	2	29908552
Pubmed	CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation.	ITGAL CD226	6.77e-05	3	166	2	14676297
Pubmed	Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities.	CACNA1C SVEP1	6.77e-05	3	166	2	27529678
Pubmed	Identification of two new members of the CSMD gene family.	CSMD2 CSMD1	6.77e-05	3	166	2	12906867
Pubmed	Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin.	CFHR4 C3	6.77e-05	3	166	2	10622723
Pubmed	PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.	ADGRV1 USH2A	6.77e-05	3	166	2	20440071
Pubmed	A genetic interaction network model of a complex neurological disease.	GABRG2 SCN8A	6.77e-05	3	166	2	25251056
Pubmed	Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit.	ITGA6 ITGA1	6.77e-05	3	166	2	18032737
Pubmed	Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.	FLT4 MTOR	6.77e-05	3	166	2	16959214
Pubmed	Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.	PSEN1 C3	6.77e-05	3	166	2	23747948
Pubmed	RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs.	HRAS ARHGEF6	6.77e-05	3	166	2	9582122
Pubmed	Activation of PERK Elicits Memory Impairment through Inactivation of CREB and Downregulation of PSD95 After Traumatic Brain Injury.	DLG4 EIF2AK3	6.77e-05	3	166	2	28522733
Pubmed	mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex.	MTOR PKD1	6.77e-05	3	166	2	26931735
Pubmed	Mutant HRAS as novel target for MEK and mTOR inhibitors.	MTOR HRAS	6.77e-05	3	166	2	26544513
Pubmed	Complement component C3 plays a critical role in protecting the aging retina in a murine model of age-related macular degeneration.	CFHR4 C3	6.77e-05	3	166	2	23747511
Pubmed	MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson's Disease by Binding to AXIN1.	SLC1A6 AXIN1	6.77e-05	3	166	2	30537735
Pubmed	Non-USH2A mutations in USH2 patients.	ADGRV1 USH2A	6.77e-05	3	166	2	22147658
Pubmed	Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex.	ATRX MTOR	6.77e-05	3	166	2	25439321
Pubmed	Differential localization of GABAA receptor subunits within the substantia nigra of the human brain: an immunohistochemical study.	GABRG2 GABRA3	6.77e-05	3	166	2	18085588
Pubmed	Live Neuron High-Content Screening Reveals Synaptotoxic Activity in Alzheimer Mouse Model Homogenates.	PSEN1 DLG4	6.77e-05	3	166	2	32098978
GeneFamily	Dyneins, axonemal	DNAH3 DNAH1 DNAH17 DNAH6 DNAH11	8.78e-08	17	126	5	536
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 SVEP1 CFHR4 CSMD1 MASP2	4.76e-05	57	126	5	1179
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA6 ITGA1 ITGAL	2.50e-04	18	126	3	1160
GeneFamily	Fibronectin type III domain containing\|USH2 complex	ADGRV1 USH2A	2.86e-04	4	126	2	1244
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL4 ADGRL2	2.86e-04	4	126	2	918
GeneFamily	Solute carriers	SLC2A9 SLC26A5 SLC25A26 SLC35F1 SLC1A6 SLC6A4 SLC44A1 MTCH1 SLC25A45	1.80e-03	395	126	9	752
GeneFamily	Complement system\|Sushi domain containing	CFHR4 C3 C8B	1.99e-03	36	126	3	492
GeneFamily	Doublecortin superfamily	DCDC2 DCDC2C	2.09e-03	10	126	2	1369
Coexpression	GSE20715_0H_VS_24H_OZONE_LUNG_DN	IL34 CP LCN2 SVEP1 ADGRL4 DOCK5 FASN C3 MASP2	4.30e-06	200	161	9	M4367
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN	CPNE8 DNAJC25 FFAR2 CHAC2 LYPD2 CP SDR42E1 UROC1 LCAT PLIN2 CFHR4 SGK2 HPD RASL11A TTLL2 DENND2C C3 TPRG1 CAPN5 C8B MASP2 SLC25A45	9.48e-06	1257	161	22	M45034
Coexpression	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	CP ITGA1 LCN2 ITGAL SPON1 C3 ALCAM	1.07e-05	122	161	7	M9399
Coexpression	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	ITGA6 LGALS3BP SMC3 TOP2A	2.16e-05	27	161	4	M5570
Coexpression	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	CP ITGA1 LCN2 ITGAL SPON1 C3 ALCAM	3.01e-05	143	161	7	MM1056
Coexpression	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP	SLC35F1 LCAT EPB41L4A PARP14 NFAM1 NSUN2 FASN MRPL11	3.22e-05	198	161	8	M6361
Coexpression	GSE17721_4H_VS_24H_POLYIC_BMDC_UP	MIOX SRP54 DEPDC1 MINPP1 NSUN2 FASN MRPL11 MAD2L1	3.34e-05	199	161	8	M4098
Coexpression	YOSHIMURA_MAPK8_TARGETS_UP	GABRG2 CACNA1C PSEN1 SI LCN2 GRM1 SLC1A6 DNAH1 DOCK5 FAT2 HPD RASL11A PTPRQ C8B ADGRL2 IL1R1 DNAH6 EIF2AK3 CNGA3 ALOX5AP GABRA3	4.02e-05	1281	161	21	M1884
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 SLC35F1 ADGRV1 GRM1 DNAH1 PTPRQ CSMD1 USH2A HYDIN EPHA7 DNAH11	9.45e-11	184	164	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 SLC35F1 ADGRV1 GRM1 DNAH1 PTPRQ CSMD1 USH2A HYDIN EPHA7 DNAH11	9.45e-11	184	164	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 SLC35F1 ADGRV1 GRM1 DNAH1 PTPRQ CSMD1 USH2A HYDIN EPHA7 DNAH11	9.45e-11	184	164	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCDC2 CP CFAP43 LCAT FAT2 TPRG1 ALCAM DNAH6 HYDIN DNAH11	1.93e-09	186	164	10	29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e
ToppCell	Adult-Endothelial\|Adult / Lineage, Cell type, age group and donor	FLT4 UNC5B ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	4.55e-08	194	164	9	963b3fbee0575af8379baa397ace65949eaf34f7
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL34 COL6A3 MXRA5 CP SVEP1 SPON1 ADGRL2 IL1R1 EPHA7	4.97e-08	196	164	9	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	LAMA5 ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB CSMD1 ADGRL2	5.66e-08	199	164	9	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	COL6A3 CPNE8 MXRA5 COL12A1 CP SVEP1 CAPN5 ADGRL2 IL1R1	5.66e-08	199	164	9	56d72da6a5fab9cbb2975fe6f87a631debaba6a8
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 MXRA5 CP SVEP1 CFHR4 ADGRL2 IL1R1 EPHA7	2.23e-07	169	164	8	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 DCDC2 HIPK4 CP FAT2 SPON1 C3 UPK2	3.31e-07	178	164	8	445fb243d738a34794d66f34b92dde1f3ea6738e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX ITGA6 SRP54 ITGA1 PARP14 ADGRL4 PTPRB SMC3	3.31e-07	178	164	8	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Mesenchymal_cells-Adipo-CAR\|Mesenchymal_cells / Lineage and Cell class	IL34 CP LGALS3BP RASL11A SPON1 C3 CSMD1 IL1R1	3.76e-07	181	164	8	1cfb03eb03a37b036b4eeacec69c9b8163af1ee4
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	IL34 CP SVEP1 RASL11A SPON1 C3 CSMD1 IL1R1	4.62e-07	186	164	8	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C COL6A3 COL12A1 CP ITGA1 SVEP1 SPON1 IL1R1	4.81e-07	187	164	8	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	UNC5B ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	5.01e-07	188	164	8	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	Ciliated-cil-3\|World / Class top	DNAH3 CFAP43 ITGAL LGALS3BP DNAH1 DNAH6 HYDIN DNAH11	5.88e-07	192	164	8	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	droplet-Kidney-nan-3m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 DCDC2 ZBTB7C LYPD2 CP RASL11A SPON1 EPHA7	5.88e-07	192	164	8	8b625c22dda23c99654c82c529a1233e99e71b54
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	UNC5B ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	6.11e-07	193	164	8	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	LAMA5 ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	6.11e-07	193	164	8	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	background-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	FLT4 SLC26A5 EPB41L4A ADGRL4 PTPRB HPD C3 ADGRL2	6.61e-07	195	164	8	c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT4 DCDC2C ITGA6 ITGA1 ADGRL4 SLC6A4 PTPRB ADGRL2	6.61e-07	195	164	8	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 SGPP2 CFAP43 MACF1 DNAH6 HYDIN TOP2A DNAH11	6.87e-07	196	164	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 SGPP2 CFAP43 MACF1 DNAH6 HYDIN TOP2A DNAH11	6.87e-07	196	164	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C COL6A3 MXRA5 COL12A1 CSMD2 SVEP1 SPON1 IL1R1	7.14e-07	197	164	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	DCDC2 CP ADGRV1 LCN2 PLXNB2 PLIN2 FASN C3	7.14e-07	197	164	8	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / Treatment groups by lineage, cell group, cell type	DCDC2 CP LCN2 PLXNB2 PLIN2 FASN C3 MTCH1	7.41e-07	198	164	8	655df75b9692d815c7f6910275e1f684ac63bf62
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LAMA5 ITGA6 ITGA1 ADGRL4 SLC6A4 PTPRB CSMD1 ADGRL2	7.41e-07	198	164	8	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	background\|World / Sample and Cell Type and Tumor Cluster (all cells)	CP GC PLIN2 HPD C3 C8B CSMD1 MASP2	7.70e-07	199	164	8	5a6d0e00bfe1351eea192b54020bedeef78854e9
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IL34 COL6A3 MXRA5 COL12A1 CP SVEP1 ADGRL2 EPHA7	7.70e-07	199	164	8	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	ILEUM-non-inflamed-(8)_Fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IL34 COL6A3 CPNE8 MXRA5 COL12A1 SVEP1 CAPN5 ADGRL2	7.70e-07	199	164	8	d9d7f36b4b5592b7855448730044c90997b55499
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL34 COL6A3 MXRA5 CP RASL11A C3 ADGRL2 IL1R1	7.70e-07	199	164	8	6139687a3a5025cb98da4dba0183f95fcae3dc61
ToppCell	background-Hepatocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	CP GC PLIN2 HPD C3 C8B CSMD1 MASP2	8.00e-07	200	164	8	423cca10df6ae0489a8fe7e7df87e70364dac022
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG2 SLC26A5 NDST4 ADGRV1 PTPRQ USH2A HYDIN	1.14e-06	145	164	7	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP43 DNAH1 USH2A DNAH6 HYDIN DNAH11	1.70e-06	154	164	7	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP43 DNAH1 USH2A DNAH6 HYDIN DNAH11	1.70e-06	154	164	7	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 ADGRV1 SVEP1 PTPRQ WDR17 USH2A HYDIN	2.20e-06	160	164	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 ADGRV1 SVEP1 PTPRQ WDR17 USH2A HYDIN	2.20e-06	160	164	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CP GC UROC1 LCAT LCN2 HPD C3	2.29e-06	161	164	7	274838cebdc7af1db32d309dfe42ef7ccd3c190b
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C CDHR2 NDST4 ADGRV1 PTPRQ USH2A HYDIN	2.39e-06	162	164	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LGALS3BP SCN8A CHEK2 TPRG1 IGHV4-30-2 TOP2A EPHA7	2.80e-06	166	164	7	7495961adcefe5c1fb288913b1a5236328a04703
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP43 DNAH1 WDR17 DNAH6 HYDIN DNAH11	3.16e-06	169	164	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 LCN2 DNAH1 USH2A DNAH6 HYDIN DNAH11	3.16e-06	169	164	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	MXRA5 ZBTB7C TPRG1 CDT1 ADGRL2 DNAH6 TOP2A	3.28e-06	170	164	7	aabe993c9f337b1caaeb0e64626a3920579c41b7
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C ZBTB7C SLC35F1 CSMD2 ALCAM CSMD1 WDR17	3.41e-06	171	164	7	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	TCGA-Liver\|World / Sample_Type by Project: Shred V9	GC UROC1 CFHR4 SERPINA4 HPD C8B MASP2	3.83e-06	174	164	7	452932f08cf53e5949672a025d78cecb874aa4b0
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 CPA1 ADGRV1 PTPRQ CSMD1 USH2A HYDIN	3.98e-06	175	164	7	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	facs-Heart-LV\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 ITGA6 GC ITGA1 LCN2 ADGRL4 PTPRB	4.13e-06	176	164	7	483e36d9bb7268bf179e69a65e1a0be099035162
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A AGBL3 LPIN1 SPON1 HYDIN EPHA7 DNAH11	4.45e-06	178	164	7	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB7C PCDHB13 LAMA5 CPT1B ADGRL4 PTPRB CAPN5	4.61e-06	179	164	7	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 DCDC2C UNC5B ITGA6 UBE2U DOCK5 PTPRB	4.61e-06	179	164	7	abc6797bd3884aa75dca58fcb2523ee321243ab1
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 DCDC2C UNC5B ITGA6 UBE2U DOCK5 PTPRB	4.61e-06	179	164	7	0b996d6e881f31e6b80d359f7caac70ecdeb9982
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCDC2 SGPP2 CP ADGRV1 LCN2 PLXNB2 C3	4.61e-06	179	164	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CFAP43 AGBL3 LPIN1 HYDIN EPHA7 DNAH11	4.96e-06	181	164	7	6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	LAMA5 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	4.96e-06	181	164	7	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 SRP54 ITGA1 ADGRL4 PTPRB RASL11A ADGRL2	4.96e-06	181	164	7	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	FLT4 LAMA5 ITGA1 EPB41L4A ADGRL4 SLC6A4 ADGRL2	4.96e-06	181	164	7	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	CACNA1C COL6A3 MXRA5 COL12A1 UNC5B SVEP1 SPON1	4.96e-06	181	164	7	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 CP LCN2 ADGRL4 PTPRB ADGRL2 IL1R1	5.15e-06	182	164	7	ccc313ecc0bfd8e2c6bb83a565b427b2310485ec
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 CP LCN2 ADGRL4 PTPRB ADGRL2 IL1R1	5.15e-06	182	164	7	b9f758961fb4a586ae86fa0b25edb8ce4616d644
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 CP LCN2 ADGRL4 PTPRB ADGRL2 IL1R1	5.15e-06	182	164	7	e6a734fb29105093d4cbfc3d0619a825b66da034
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MIOX GC ADGRV1 SPON1 CSMD1 USH2A EPHA7	5.33e-06	183	164	7	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPZ COL12A1 DOCK5 SLC6A4 CD226 SCN8A CSMD1	5.53e-06	184	164	7	e33bb572af9dfd11127105f1ac99bc958a7cafbb
ToppCell	Ciliated_cells-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 CP CFAP43 LCN2 DNAH6 HYDIN DNAH11	5.53e-06	184	164	7	07c5a9633ccdcd18771e3230d6198a55c400afa6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A CFAP43 SPON1 DNAH6 HYDIN EPHA7 DNAH11	5.93e-06	186	164	7	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHB8 NDST4 GC LGALS3BP ALCAM C8B DNAH11	5.93e-06	186	164	7	16092819e9148dfe64f07c737652b6e533e699f7
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	AARS1 LAMA5 HSPA13 SLC44A1 DENND2C IGHV4-39 EIF2AK3	5.93e-06	186	164	7	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	droplet-Heart-HEART-1m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPZ SLC35F1 EPB41L4A SLC6A4 CD226 CSMD1 DNAH11	5.93e-06	186	164	7	fddc6b93f98b10aaf8d4ebc142b46d8213f3129d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C ZBTB7C SLC35F1 CSMD2 RASL11A CSMD1 WDR17	5.93e-06	186	164	7	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	CACNA1C COL6A3 ITGA1 KCNB2 SVEP1 SPON1 ADGRL2	6.15e-06	187	164	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	6.15e-06	187	164	7	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DCDC2 COL12A1 LAMA5 EPB41L4A DOCK5 PTPRQ ALCAM	6.36e-06	188	164	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL34 MPZ DCDC2 LYPD2 CP SPON1 EPHA7	6.36e-06	188	164	7	c300accbac71a3bc075fe985543d8a8ead82531b
ToppCell	facs-GAT-Fat-24m-Endothelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 UNC5B LAMA5 ITGA6 ITGA1 ADGRL4 PTPRB	6.82e-06	190	164	7	da2fcd4a2cc6e45c8174109d892f1424e39919a1
ToppCell	facs-GAT-Fat-24m-Endothelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 UNC5B LAMA5 ITGA6 ITGA1 ADGRL4 PTPRB	6.82e-06	190	164	7	3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 UNC5B ITGA6 ITGA1 ADGRL4 PTPRB CHEK2	6.82e-06	190	164	7	5174f91a880f85bb20806023aa68bd4b8ca24ea5
ToppCell	facs-MAT-Fat-18m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 LAMA5 ITGA6 ITGA1 ADGRL4 PTPRB CHEK2	6.82e-06	190	164	7	9aaa48f3aad813c87a45efdbb67d255c94f6e6a4
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 UNC5B ITGA6 ITGA1 ADGRL4 PTPRB CHEK2	6.82e-06	190	164	7	90e494cbfbed33a3a0d29bb7dae83f0c81580bcf
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	6.82e-06	190	164	7	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	facs-MAT-Fat-18m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 LAMA5 ITGA6 ITGA1 ADGRL4 PTPRB CHEK2	6.82e-06	190	164	7	34e56c5e7ea6a8f227dbaefe73cbb8818d18b523
ToppCell	facs-MAT-Fat-18m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 LAMA5 ITGA6 ITGA1 ADGRL4 PTPRB CHEK2	6.82e-06	190	164	7	14cdb660ad3aabcf49572173e7628d8b99dcbe6f
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 UNC5B ITGA6 ITGA1 ADGRL4 PTPRB CHEK2	6.82e-06	190	164	7	c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073
ToppCell	facs-GAT-Fat-24m-Endothelial-endothelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 UNC5B LAMA5 ITGA6 ITGA1 ADGRL4 PTPRB	6.82e-06	190	164	7	e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	CPNE8 ZBTB7C ITGA6 EPB41L4A ADGRL4 PTPRB ADGRL2	6.82e-06	190	164	7	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	CPNE8 FLT4 UNC5B EPB41L4A ADGRL4 PTPRB ADGRL2	7.30e-06	192	164	7	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	CTRL-Myeloid-Alveolar_Macrophage\|Myeloid / Disease state, Lineage and Cell class	SLC2A9 EPB41L4A ITGAL LGALS3BP PLIN2 TPRG1 ALOX5AP	7.55e-06	193	164	7	80871d963c23a6befe58e5e60b7f7d1a1b227ce2
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C COL6A3 COL12A1 ITGA1 KCNB2 SPON1 IL1R1	7.55e-06	193	164	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1C FLT4 ITGA1 PLIN2 ADGRL4 PTPRB ADGRL2	7.55e-06	193	164	7	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA5 ITGA6 ITGA1 ADGRL4 SLC6A4 PTPRB ADGRL2	7.81e-06	194	164	7	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	7.81e-06	194	164	7	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLT4 SGPP2 ITGA6 ITGA1 ADGRL4 PTPRB ADGRL2	7.81e-06	194	164	7	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CACNA1C COL6A3 MXRA5 ITGA1 CSMD2 SVEP1 SPON1	7.81e-06	194	164	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLT4 SGPP2 ITGA6 ITGA1 ADGRL4 PTPRB ADGRL2	7.81e-06	194	164	7	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	CPNE8 LAMA5 ITGA6 ITGA1 PARP14 ADGRL4 PTPRB	8.08e-06	195	164	7	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C COL6A3 COL12A1 ITGA1 SVEP1 SPON1 IL1R1	8.08e-06	195	164	7	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IL34 COL6A3 COL12A1 CP ITGA1 SVEP1 C3	8.08e-06	195	164	7	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRG2 CACNA1C KCNB2 PKD1 SCN8A CSMD1 ADGRL2	8.35e-06	196	164	7	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLT4 UNC5B SGPP2 ITGA6 ITGA1 ADGRL4 PTPRB	8.35e-06	196	164	7	ed818de15f84f7f28bd06fd69d7876710da232a0
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGA6 ITGA1 EPB41L4A ADGRL4 SLC6A4 PTPRB ADGRL2	8.35e-06	196	164	7	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	FLT4 ITGA6 ITGA1 ADGRL4 SLC6A4 PTPRB ADGRL2	8.35e-06	196	164	7	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 MXRA5 NDST4 LAMA5 LGALS3BP ADGRL4 IL1R1	8.63e-06	197	164	7	ea746772adb9df4ddb0508d4ef35f2027bf09c35
Disease	Liver carcinoma	CP DEPDC1 UROC1 LCAT AXIN1 FASN SERPINA4 MTOR HRAS CDT1 CSMD1 TOP2A MAD2L1	4.03e-06	507	159	13	C2239176
Disease	Complement deficiency disease	CFHR4 C3 C8B MASP2	2.94e-05	33	159	4	C0272242
Disease	Neoplasm of uncertain or unknown behavior of bladder	ERCC2 MTOR HRAS	6.66e-05	15	159	3	C0496930
Disease	Benign neoplasm of bladder	ERCC2 MTOR HRAS	6.66e-05	15	159	3	C0154017
Disease	Carcinoma in situ of bladder	ERCC2 MTOR HRAS	6.66e-05	15	159	3	C0154091
Disease	volumetric bone mineral density	CACNA1C ADGRV1 AXIN1 SMC3	7.75e-05	42	159	4	EFO_0007620
Disease	Tremor, Rubral	CP UROC1 SCN8A	8.17e-05	16	159	3	C0750940
Disease	Ataxia, Appendicular	CP UROC1 SCN8A	8.17e-05	16	159	3	C0750937
Disease	Ataxia, Motor	CP UROC1 SCN8A	8.17e-05	16	159	3	C0278161
Disease	Ataxia, Sensory	CP UROC1 SCN8A	8.17e-05	16	159	3	C0240991
Disease	Abnormal coordination	CP UROC1 SCN8A	8.17e-05	16	159	3	C0520966
Disease	Ataxia, Truncal	CP UROC1 SCN8A	8.17e-05	16	159	3	C0427190
Disease	glioblastoma (is_marker_for)	ATRX ADGRL4 PTPRB HRAS	9.32e-05	44	159	4	DOID:3068 (is_marker_for)
Disease	Drug toxicity	CP GC LCN2 C3 EPHA7	9.34e-05	84	159	5	C0013221
Disease	Adverse reaction to drug	CP GC LCN2 C3 EPHA7	9.34e-05	84	159	5	C0041755
Disease	Antibody Deficiency Syndrome	CACNA1C C3 C8B	9.88e-05	17	159	3	C0003257
Disease	cancer (implicated_via_orthology)	FLT4 ITGA6 AXIN1 MTOR HRAS MACF1 DLG4 TOP2A	1.08e-04	268	159	8	DOID:162 (implicated_via_orthology)
Disease	Carcinoma of bladder	ERCC2 MTOR HRAS	1.18e-04	18	159	3	C0699885
Disease	Neuroblastoma	ATRX CHEK2 HRAS TOP2A	1.21e-04	47	159	4	C0027819
Disease	Sclerocystic Ovaries	IL34 FLT4 DLG4 TOP2A MAD2L1 ZMYM5	1.35e-04	144	159	6	C1136382
Disease	Polycystic Ovary Syndrome	IL34 FLT4 DLG4 TOP2A MAD2L1 ZMYM5	1.35e-04	144	159	6	C0032460
Disease	complement factor H-related protein 4 measurement	SGPP2 CFHR4 SPON1 ADGRL2	1.42e-04	49	159	4	EFO_0600091
Disease	Neurodevelopmental Disorders	KMT2E SMC3 SCN8A DLG4 ZNF292	1.51e-04	93	159	5	C1535926
Disease	Intellectual Disability	PIGB UROC1 KMT2E NSUN2 FASN MTOR SCN8A MACF1 DLG4 ZNF292	1.65e-04	447	159	10	C3714756
Disease	Ullrich congenital muscular dystrophy	COL6A3 COL12A1	1.72e-04	4	159	2	cv:C4551860
Disease	Bethlem myopathy	COL6A3 COL12A1	1.72e-04	4	159	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A3 COL12A1	1.72e-04	4	159	2	C1834674
Disease	autosomal dominant polycystic kidney disease (is_implicated_in)	MTOR PKD1	1.72e-04	4	159	2	DOID:898 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy 1	COL6A3 COL12A1	1.72e-04	4	159	2	C0410179
Disease	Bethlem myopathy (is_implicated_in)	COL6A3 COL12A1	1.72e-04	4	159	2	DOID:0050663 (is_implicated_in)
Disease	Thyroid cancer, nonmedullary, 2	MINPP1 HRAS	1.72e-04	4	159	2	cv:C4225426
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A3 COL12A1	1.72e-04	4	159	2	DOID:0050558 (is_implicated_in)
Disease	THYROID CANCER, NONMEDULLARY, 2	MINPP1 HRAS	1.72e-04	4	159	2	188470
Disease	Immunologic Deficiency Syndromes	CACNA1C C3 C8B	2.51e-04	23	159	3	C0021051
Disease	THYROID CANCER, NONMEDULLARY, 2	MINPP1 HRAS	2.85e-04	5	159	2	C4225426
Disease	obsessive-compulsive disorder (is_implicated_in)	SLC6A4 HRAS	2.85e-04	5	159	2	DOID:10933 (is_implicated_in)
Disease	Schizophrenia	GABRG2 CACNA1C DCDC2 CP GC LCN2 GRM1 CSMD2 SLC1A6 SLC6A4 KCNH6 MTOR DLG4 CSMD1	3.18e-04	883	159	14	C0036341
Disease	Ataxia	CP UROC1 SCN8A	3.24e-04	25	159	3	C0004134
Disease	glucagon measurement, glucose tolerance test	SPON1 MACF1	4.27e-04	6	159	2	EFO_0004307, EFO_0008463
Disease	Cannabis use	ADGRL4 SLC6A4	4.27e-04	6	159	2	C3160814
Disease	Hemimegalencephaly	MTOR HRAS	4.27e-04	6	159	2	C0431391
Disease	Mental Depression	CACNA1C PSEN1 GRM1 CSMD2 SLC6A4 DLG4 GABRA3	4.74e-04	254	159	7	C0011570
Disease	neutrophil count	FOXJ2 MPZ DNAJC13 FFAR2 GC SLC25A26 LCN2 KMT2E ITGAL ADGRL4 SLC6A4 TRAP1 CD226 PKD1 CHEK2 ADGRL2 HYDIN ZNF292	4.90e-04	1382	159	18	EFO_0004833
Disease	atypical femoral fracture, response to bisphosphonate	CACNA1C CPNE8 CSMD1 MTCH1	5.06e-04	68	159	4	EFO_0009958, EFO_0009960
Disease	Autistic Disorder	CACNA1C CP KMT2E SLC6A4 HRAS GABRA3 ZNF292	5.57e-04	261	159	7	C0004352
Disease	urate measurement, bone density	GABRG2 SLC2A9 SLC26A5 LAMA5 MINPP1 C7orf33 DNAH1 DOCK5 TPRG1 USH2A DNAH11	5.59e-04	619	159	11	EFO_0003923, EFO_0004531
Disease	Thyroid cancer, follicular	MINPP1 HRAS	5.95e-04	7	159	2	C2931367
Disease	Amphetamine-Related Disorders	GABRG2 DCSTAMP SLC6A4 CSMD1	7.33e-04	75	159	4	C0236733
Disease	Amphetamine Abuse	GABRG2 DCSTAMP SLC6A4 CSMD1	7.33e-04	75	159	4	C0236807
Disease	Amphetamine Addiction	GABRG2 DCSTAMP SLC6A4 CSMD1	7.33e-04	75	159	4	C0236804
Disease	urinary bladder cancer (is_implicated_in)	ERCC2 AXIN1 CHEK2 HRAS	7.70e-04	76	159	4	DOID:11054 (is_implicated_in)
Disease	coronary aneurysm	UNC5B CSMD2 CSMD1	8.85e-04	35	159	3	EFO_1000881
Disease	Primary ciliary dyskinesia	DNAH1 HYDIN DNAH11	9.62e-04	36	159	3	cv:C0008780
Disease	Depressive disorder	CACNA1C PSEN1 GRM1 CSMD2 SLC6A4 DLG4 GABRA3	1.01e-03	289	159	7	C0011581
Disease	Atypical hemolytic-uremic syndrome	CFHR4 C3	1.01e-03	9	159	2	cv:C2931788
Disease	acoustic startle blink response measurement	CACNA1C PARP14	1.01e-03	9	159	2	EFO_0006875
Disease	Hemolytic-uremic syndrome	CFHR4 C3	1.01e-03	9	159	2	cv:C0019061
Disease	Generalized Epilepsy with Febrile Seizures Plus	GABRG2 ADGRV1	1.01e-03	9	159	2	C3502809
Disease	colon cancer (biomarker_via_orthology)	LCN2 AXIN1 MTOR	1.22e-03	39	159	3	DOID:219 (biomarker_via_orthology)
Disease	thyroid gland papillary carcinoma (is_implicated_in)	MINPP1 HRAS	1.26e-03	10	159	2	DOID:3969 (is_implicated_in)
Disease	glucagon-like peptide-1 measurement	COL12A1 CSMD1	1.26e-03	10	159	2	EFO_0008465
Disease	abdominal aortic calcification measurement	PLIN2 PIK3R4	1.26e-03	10	159	2	EFO_0010272
Disease	response to anticoagulant	CACNA1C MPZ EPHA7	1.41e-03	41	159	3	GO_0061476
Disease	high grade glioma (is_implicated_in)	ERCC2 ATRX SLC44A1	1.51e-03	42	159	3	DOID:3070 (is_implicated_in)
Disease	autistic disorder (is_implicated_in)	KMT2E SLC6A4 HRAS	1.51e-03	42	159	3	DOID:12849 (is_implicated_in)
Disease	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	KCNB2 DNAH11	1.54e-03	11	159	2	EFO_0009923
Disease	Colorectal Carcinoma	DNAH3 ERCC2 GRM1 KCNB2 LPIN1 CD226 RASL11A CHEK2 ABCD4 ZNF292 EPHA7	1.54e-03	702	159	11	C0009402
Disease	myeloid white cell count	DNAJC13 GC KMT2E ITGAL ADGRL4 SLC6A4 TRAP1 SLC44A1 CD226 PKD1 C3 CDT1 ZNF292	1.75e-03	937	159	13	EFO_0007988
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	GABRG2 SCN8A	1.84e-03	12	159	2	DOID:0060170 (implicated_via_orthology)
Disease	thyroid gland carcinoma (is_marker_for)	FLT4 PTPRB	1.84e-03	12	159	2	DOID:3963 (is_marker_for)
Disease	epilepsy (implicated_via_orthology)	GABRG2 ITGA6 SLC1A6 KCNH6 SCN8A	1.94e-03	163	159	5	DOID:1826 (implicated_via_orthology)
Disease	heart rate variability measurement, response to antipsychotic drug	COL12A1 ALCAM CSMD1	1.97e-03	46	159	3	EFO_0008003, GO_0097332
Disease	Disease Exacerbation	TRAP1 CHEK2 HRAS ABCD4 TOP2A	2.05e-03	165	159	5	C0235874
Disease	Primary Ciliary Dyskinesia	DNAH1 HYDIN DNAH11	2.09e-03	47	159	3	C4551720
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	LCN2 C3	2.16e-03	13	159	2	DOID:332 (biomarker_via_orthology)
Disease	Fulminant Hepatic Failure with Cerebral Edema	GABRG2 GC	2.16e-03	13	159	2	C0751197
Disease	Hepatic Stupor	GABRG2 GC	2.16e-03	13	159	2	C0751198
Disease	Hepatic Encephalopathy	GABRG2 GC	2.16e-03	13	159	2	C0019151
Disease	Hepatic Coma	GABRG2 GC	2.16e-03	13	159	2	C0019147
Disease	Acute kidney injury	CP GC LCN2 C3	2.21e-03	101	159	4	C2609414
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	CACNA1C ADGRL4 CSMD1 IL1R1	2.21e-03	101	159	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	Acute Kidney Insufficiency	CP GC LCN2 C3	2.21e-03	101	159	4	C1565662
Disease	Kidney Failure, Acute	CP GC LCN2 C3	2.21e-03	101	159	4	C0022660
Disease	complement factor H-related protein 3 measurement	COL12A1 ADGRV1 CFHR4 TPRG1 USH2A	2.27e-03	169	159	5	EFO_0600056
Disease	melanoma	ERCC2 PCDHB8 CP FASN HRAS SLC25A45	2.32e-03	248	159	6	C0025202
Disease	vitamin D measurement, COVID-19	SDR42E1 GC SPON1	2.36e-03	49	159	3	EFO_0004631, MONDO_0100096
Disease	Malformations of Cortical Development	MTOR HRAS	2.52e-03	14	159	2	C1955869
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 KIF28P	2.52e-03	14	159	2	DOID:898 (implicated_via_orthology)
Disease	Cortical Dysplasia	MTOR HRAS	2.52e-03	14	159	2	C0431380
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	DCDC2 SLC26A5 PTPRQ	2.65e-03	51	159	3	cv:CN043650
Disease	Unipolar Depression	CACNA1C GRM1 SLC1A6 SLC6A4 MTOR DLG4	2.88e-03	259	159	6	C0041696
Disease	response to olanzapine	CACNA1C ADGRV1	2.89e-03	15	159	2	GO_0097333
Disease	hepatocellular carcinoma (is_implicated_in)	ERCC2 GC AXIN1 SMC3 HRAS	3.05e-03	181	159	5	DOID:684 (is_implicated_in)
Disease	total blood protein measurement	DNAH3 DNAJC13 ITGA1 DNAH1 SLC6A4 PKD1 MACF1 HYDIN	3.11e-03	449	159	8	EFO_0004536
Disease	Metastatic melanoma	FLT4 MTOR EPHA7	3.11e-03	54	159	3	C0278883
Disease	pulmonary hypertension (implicated_via_orthology)	SLC6A4 MTOR ALOX5AP	3.11e-03	54	159	3	DOID:6432 (implicated_via_orthology)
Disease	apolipoprotein B measurement	IL34 ERCC2 DNAJC13 PSEN1 ITGA1 SLC6A4 DLG4 C8B HYDIN DNAH11	3.29e-03	663	159	10	EFO_0004615
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	MTOR PKD1	3.29e-03	16	159	2	DOID:0110861 (implicated_via_orthology)
Disease	Drug-induced agranulocytosis	SCN8A ADGRL2	3.29e-03	16	159	2	HP_0012235
Disease	Charcot-Marie-Tooth disease type 2	MPZ AARS1	3.72e-03	17	159	2	cv:C0270914

Protein segments in the cluster

Peptide	Gene	Start	Entry
AVAFVYYKSIGPLLS	ADGRL4	296	Q9HBW9
KYFVGYLGERTQSTP	ALOX5AP	96	P20292
YALFKIATPARYTVT	FAM210A	191	Q96ND0
YRFTIVNFTKPASLY	AGBL3	221	Q8NEM8
GSVYIYTFGKEPTLN	CFAP43	366	Q8NDM7
YRKPFYTIDLNSILT	ERVK-18	251	O42043
GFETAPLTKNYYTVV	ARHGEF6	231	Q15052
YYEYLGKRQPATLTV	CSMD1	3361	Q96PZ7
LYFVTVPKDYVVFGQ	CSMD2	1646	Q7Z408
KNSGYISRYLTDFEP	EIF2AK3	581	Q9NZJ5
TYEGRPIYVLKFSTG	CPA1	151	P15085
PGERYKYIFINITDN	ADGRV1	1781	Q8WXG9
YITVGDKYVSQFNRP	C4orf47	21	A7E2U8
EIPYFTTSGIQVRYL	AP1M1	381	Q9BXS5
VGQIKTVYPASYRFR	CDT1	236	Q9H211
KTIYTPGSTVLYRIF	C3	136	P01024
VKFPSQGTIFDYYVD	DNAH11	2441	Q96DT5
YKLPNRVDGTGFVVY	ADGRL2	201	O95490
GTSTPEYNVKGIFYR	CAPN5	556	O15484
ASKLIISPFTLVYYT	ABCD4	161	O14678
IFREVGPKNSYIAYI	CHEK2	146	O96017
YKPGRTVTSSYLNVR	C7orf33	141	Q8WU49
YLKSFYIRSTDPTQI	AP3B2	376	Q13367
SYGIPYIETSAKTRQ	HRAS	136	P01112
ATPAVRTVPQYKYAA	PABPC1	501	P11940
TIYQGTLLFIYSRPS	OR5I1	251	Q13606
EGIYTLYPFINSRII	NSUN2	606	Q08J23
KVVYRQYTDSTFRVP	CP	781	P00450
YVYARPFTALPTEKA	OR4D11	256	Q8NGI4
YIISPNSYFRVLTRK	PCDHB13	171	Q9Y5F0
TEYRFTSLTPGRQYK	PTPRB	871	P23467
SYNPKQDRFISLVYT	OR10W1	256	Q8NGF6
FRITPYDVQLGYSVL	MDN1	2011	Q9NU22
ERYLGVAFPVQYKLS	FFAR2	106	O15552
GIYPSETFTRVQKYG	MAD2L1	36	Q13257
GLNLTEDTYKPRIYT	LGALS3BP	396	Q08380
SEVRYVKEPYIQSRF	HIPK4	166	Q8NE63
GSTYYNPSLKSRVTI	IGHV4-30-2	76	A0A087WSY4
GPSVQDKYVTALYFT	KCNH6	456	Q9H252
GSTYYNPSLKSRVTI	IGHV4-30-4	76	P0DP06
GIPVLDYKTYTDRVF	PLXNB2	1271	O15031
FQSPYYKVRVPENIT	FAT2	2171	Q9NYQ8
ASFYPSVERKRIQYL	DCSTAMP	406	Q9H295
YYNPSLKSRVTISVD	IGHV4-39	86	P01824
YPLIYQKRFPTTESE	DEPDC1	771	Q5TB30
SSPEIKRRTYSQEGY	KMT2E	956	Q8IZD2
RPADVYSYKQVGVSL	LPIN1	801	Q14693
FGVPYVYTQSRILKA	ERCC2	621	P18074
PLKFGSYAYTTAEVV	GABRA3	206	P34903
TQVLKGISPYFGYSI	ITGA6	461	P23229
KPRYSYATLITYAIN	FOXJ2	66	Q9P0K8
PTVTRRYYYSIKDIS	LAMA5	281	O15230
VLVVPENVYSFGYLR	LAMA5	1376	O15230
EVQKFLGVTPRYNYS	NDST4	781	Q9H3R1
FEKIGYTEVQFRPYR	CYHR1	226	Q6ZMK1
SIPVKYEVGLQFYSS	ITGA1	941	P56199
KPGTVYVFQIRAFTA	EPHA7	506	Q15375
KTTLYSREIVYPFQG	LYPD2	51	Q6UXB3
VITYVSSIYDAFPKV	MACF1	286	Q9UPN3
PTIVTGKFSYRVELY	PTPRQ	371	Q9UMZ3
NIKSYPGLTSYLVRV	LCN2	116	P80188
YKYRSIAIPAISSGV	PARP14	911	Q460N5
RLSKYNTEEFITVYP	OTULIN	306	Q96BN8
SYLATVPKYRIQATE	DNAJC25	176	Q9H1X3
TILFNVLPYKATDTY	DNAH1	1171	Q9P2D7
QTKPVYVYRFLAQGT	ATRX	2156	P46100
YTFKVTISVSDPYIQ	CDHR2	91	Q9BYE9
LSFKYSVIPTYRDQA	DNAH6	4016	Q9C0G6
NYKISVPYEGVFRIA	IL34	61	Q6ZMJ4
FSLKGRPTTAYIYIT	HYDIN	3531	Q4G0P3
LYYNVSFRVIPSGII	HYDIN	4821	Q4G0P3
PYYVTIFLTESNKSV	KCNB2	276	Q92953
DKGPIYNYRVEISIF	CACNA1C	1151	Q13936
RTTYTTAYTFPGILK	DOCK5	1486	Q9H7D0
NFQPFLTRTEVYKTG	SDR42E1	306	Q8WUS8
QPETKYRISVFATYS	COL12A1	966	Q99715
IKFPSQGTIFDYYID	DNAH17	2386	Q9UFH2
RYNYTTPKTFLEQIK	DNAH17	3011	Q9UFH2
LTGVSQNYARKYTIP	DNAH3	3976	Q8TD57
KTIVVYRNGDPFYVG	DCDC2C	16	A8MYV0
IYLEYTRTGSESPKV	AXIN1	206	O15169
PEFYLKTYRSQAPVL	COL6A3	1486	P12111
VEYGTLHYFVSNRKP	GABRG2	351	P18507
TFRYLSESGVTPYKE	DENND2C	216	Q68D51
LTYRQIKYFSFPGEL	SLC1A6	81	P48664
SFLLKVYVPQSRVEY	CFHR4	471	Q92496
YTGSNVLPVARFLKY	DNAJC13	1131	O75165
VTIIAQYKPEEYSRF	DLG4	386	P78352
VKSRYPGLYSRIQEF	MAN2C1	306	Q9NTJ4
RVEYITGPGVTTYKA	MASP2	376	O00187
YFQIITVTTDKPRAY	ITIH6	1141	Q6UXX5
GAIYLYFVLPETKNR	SLC2A9	491	Q9NRM0
YFVLPETKNRTYAEI	SLC2A9	496	Q9NRM0
QIRVPGFGKTYSVEY	LCAT	121	P04180
VVTYYFTRDKRNLPF	SLC44A1	411	Q8WWI5
IYQTYGFVPSRKEEI	HSPA13	271	P48723
TINLYPLTNYTFGTK	NUDT21	36	O43809
IRKPYAERVYFLNST	CD226	71	Q15762
FVPIYFGSNYKIITT	GRM1	801	Q13255
PTYVLAYTQSYRAKL	FASN	2341	P49327
TAGYVSEYRFVPDQK	EPB41L4A	156	Q9HCS5
YFLGLTPVGVVVYKN	EPB41L4A	221	Q9HCS5
YRGYKSTVLREIPFS	SLC25A26	141	Q70HW3
ESPYINGRYYSKIII	ALCAM	461	Q13740
TYLGKQYPITRVIEF	IL1R1	201	P14778
LNTRFRKPYNVESYT	C8B	206	P07358
YRSLKSVQLYGPTNF	CPNE8	401	Q86YQ8
VKSVLVYRNGDPFYA	DCDC2	16	Q9UHG0
IGYRIYDLPNTIYTK	KIF28P	726	B7ZC32
YLVSKYLGVSSPFLA	CPT1B	661	Q92523
YGVFLRVSEVKPSYR	PURB	241	Q96QR8
VTFIYRDPGSYLVTV	PKD1	1431	P98161
YIISPNSYFRVLTRK	PCDHB8	171	Q9UN66
YTSGPLLDRVFTTYK	MIOX	31	Q9UGB7
QLVASTGYVVEPYRK	MTOR	846	P42345
RTFEIKIGQPTVSYF	MRPL11	76	Q9Y3B7
LEFLSVPSTYYKQLR	HPD	286	P32754
FEGKRYFQTTLTPVE	GARIN2	341	Q8N9W8
VLGRKVLYLPSFFTY	MTCH1	121	Q9NZJ7
TIIALFYYPLEGSKS	PIGB	201	Q92521
YEPNTGKLYSRLVYV	RASL11A	56	Q6T310
ALLPYFVYVVSGVKS	TAF6L	191	Q9Y6J9
VEGLKPYRIYEFTIT	USH2A	1431	O75445
FYKPGTSYRVTLSAA	SPON1	71	Q9HCB6
ESAGFSRSNPYYIVK	SMC3	126	Q9UQE7
NATKARIPFYGSYTE	SRP54	151	P61011
LVGLRYSFQTPEKLY	SGK2	96	Q9HBY8
YTRKDGQLIYTPFTE	PSEN1	106	P49768
LLTVIYRTQSPSYKV	SLC26A5	496	P58743
RFYYLIASETPGKNI	SERPINA4	61	P29622
RITYPYTPQFKVFTV	NFAM1	66	Q8NET5
RNLTYSAPLYVDITK	POLR2B	116	P30876
KITSQIFIGPTYYQR	POLR2B	1036	P30876
YVKRTIPEYVPAFAN	SLFN11	226	Q7Z7L1
YTYIIRTILKFPSVQ	OR6C68	216	A6NDL8
VSITYGSCIFIYIKP	OR6C68	246	A6NDL8
VRVYYVATSSDQPLK	WDR17	546	Q8IZU2
YVKEFTGPTVSDTLY	SI	176	P14410
LPVTLRGSNYTSKYL	ITGAL	81	P20701
TFSSKNYVVPRVDYI	SVEP1	126	Q4LDE5
SESVPRFIKYTGYGN	RIC8A	401	Q9NPQ8
RLEIEVPYKFVTYTS	SGPP2	366	Q8IWX5
KATAPVSFNYYGVVT	BROX	11	Q5VW32
GYRTTTVIFYPKDPT	CHAC2	86	Q8WUX2
LAYLKVGTNYPEVRF	CNGA3	261	Q16281
PSVSYYRKIIEGTEV	PIK3R4	1286	Q99570
TSTYIAQDPRVYKQF	SLC35F1	356	Q5T1Q4
TVVPDTSRIYVALGY	UXT	81	Q9UBK9
YFGTKTRYEDVNPVL	MINPP1	46	Q9UNW1
KVLPLAYSQETVSFY	MINPP1	441	Q9UNW1
YFEAIQKGTGARPYT	AARS1	266	P49588
TLRDTPTVGIYFITY	SLC25A45	171	Q8N413
VIPNYSSRTEYEKLF	UROC1	181	Q96N76
GQDERLIYFYVTTIP	FLT4	541	P35916
YISRKYFATRPGAIE	TPRG1	61	Q6ZUI0
AIQSYVKARPYLTSE	ZNF292	81	O60281
VLYSRKFPSGTFEQV	GC	46	P02774
FLRTKQTLGYHVYPT	NRDC	951	O43847
PYYLTQKTFVVLNRG	SCN8A	86	Q9UQD0
REKYTYNITPFPATV	TBC1D30	526	Q9Y2I9
ATEYYRTPLLKVPNF	UBE2U	191	Q5VVX9
KPLTIYVYQEGLVRF	TTLL2	266	Q9BWV7
RYLNYFATKASPTGV	UNC5B	891	Q8IZJ1
NYREVTFVPGLYKIF	TOP2A	71	P11388
VVYFARAPKSIEVYS	WRNIP1	581	Q96S55
VTNLVPGTKFYISYL	UPK2	106	O00526
KLFTAGTLASQPYVY	ZBTB7C	61	A1YPR0
GRKFSETYYTRILPN	ZMYM5	556	Q9UJ78
ETYYTRILPNGEKTT	ZMYM5	561	Q9UJ78
YKTDAPLNIRSIFYV	TRAP1	331	Q12931
VQKPSYYVRLGSLST	PLIN2	211	Q99541
VYSPESNVRKTGSYI	PPIP5K2	221	O43314
TYIAYRLIITPGTFK	SLC6A4	591	P31645
EKTAEQGGTPIRYYF	VPS13D	3971	Q5THJ4
LSIPKVQVSDSGYYR	MXRA5	636	Q9NR99
YTYVGSILIVINPFK	MYO9A	176	B2RTY4
QVTLYVFEKVPTRYG	MPZ	141	P25189